Seeking Alpha

Analysts see strong opposition to the $29B merger of Express Scripts (ESRX) and Medco (MHS),...

Analysts see strong opposition to the $29B merger of Express Scripts (ESRX) and Medco (MHS), which would leave the industry with just one other independent company, CVS. “It’s going to be a very tough fight through the Federal Trade Commission,” industry consultant Adam Fein says, expecting pharmacists and drug makers to try to block the deal.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)